- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech Undervalued over 20% based on DCF
U.S. Pharmaceuticals & Biotech Undervalued over 20% based on DCF
UPDATED Apr 27, 2024
Companies which are undervalued more than 20% based on the Discounted Cash Flow valuation.
29 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
JNJ | US$146.14 | -1.2% | -10.7% | US$352.2b | US$173.60 | PE18.4x | E5.1% | 3.4% | ||
AMGN | US$269.98 | 0.4% | 12.6% | US$144.8b | US$300.27 | PE21.6x | E8.9% | 3.3% | ||
VRTX | US$397.48 | 0.8% | 16.7% | US$102.7b | US$459.72 | PE28.4x | E11.5% | n/a | ||
IQV | US$234.88 | 3.0% | 24.8% | US$42.8b | US$275.38 | PE31.5x | E12.9% | 0% | ||
A | US$137.74 | 3.8% | 1.7% | US$40.4b | US$150.51 | PE32.7x | E9.1% | 0.7% | ||
AVTR | US$23.94 | -0.7% | 22.9% | US$16.3b | US$27.75 | PE62.5x | E34.8% | n/a | ||
RVTY | US$101.51 | 0.6% | -22.2% | US$12.5b | US$123.24 | PE69.9x | E23.9% | 0.3% | ||
CRL | US$229.03 | 1.0% | 20.5% | US$11.8b | US$270.67 | PE24.8x | E11.4% | n/a | ||
NTRA | US$91.66 | 7.5% | 80.7% | US$11.2b | US$103.12 | PS10.4x | E68.7% | n/a | ||
CRSP | US$53.91 | -2.1% | 10.2% | US$4.6b | US$88.13 | PS12.3x | E37.6% | n/a | ||
SYNH | US$42.98 | 0.6% | -8.8% | US$4.5b | US$42.63 | PE62.6x | E33.7% | n/a | ||
IMCR | US$58.46 | 5.0% | 0.7% | US$3.0b | US$83.86 | PS11.8x | E27.7% | n/a | ||
ARWR | US$22.12 | -0.9% | -37.5% | US$2.7b | US$53.66 | PS15.1x | E20.9% | n/a | ||
DNLI | US$15.43 | -3.6% | -37.9% | US$2.2b | US$40.27 | PS6.7x | E8.1% | n/a | ||
KROS | US$57.86 | -0.7% | 30.4% | US$2.1b | US$88.11 | PS13820.4x | E14.4% | n/a | ||
MRVI | US$7.70 | 5.5% | -44.2% | US$1.9b | US$9.78 | PS3.5x | E126.7% | n/a | ||
GYRE | US$17.11 | 10.3% | n/a | US$1.5b | n/a | PS12.9x | n/a | n/a | ||
INVA | US$15.26 | 2.1% | 30.1% | US$964.8m | US$15.00 | PE5.4x | S5.5% | 0% | ||
LAB | US$2.44 | -3.2% | 43.5% | US$933.2m | US$3.58 | PS8.8x | E46.7% | n/a | ||
BLFS | US$17.53 | 10.5% | -0.2% | US$794.1m | US$23.13 | PS5.5x | E62.1% | n/a | ||
CRGX | US$18.68 | -2.7% | n/a | US$735.4m | US$32.00 | PB1.8x | E6.6% | n/a | ||
SIGA | US$8.79 | 5.4% | 50.8% | US$625.2m | n/a | PE9.2x | S8.8% | 6.8% | ||
MLAB | US$103.19 | 2.4% | -38.0% | US$556.6m | US$130.00 | PE587.1x | E108.3% | 0.6% | ||
OABI | US$4.48 | -4.1% | 28.7% | US$524.7m | US$10.00 | PS15.4x | E18.6% | n/a |